Annual report pursuant to Section 13 and 15(d)

Supplemental Balance Sheet and Cash Flow Information - Changes in Carrying Amount of Goodwill (Details)

v3.22.2.2
Supplemental Balance Sheet and Cash Flow Information - Changes in Carrying Amount of Goodwill (Details) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Beginning balance $ 843,067 $ 728,310
Acquisitions   102,818
Acquisitions (4,407)  
Eminence impairment (8,275)  
Currency translation (8,284) 11,939
Ending balance 822,101 843,067
Protein Sciences [Member]    
Beginning balance 392,717 373,081
Acquisitions   7,848
Eminence impairment (8,275)  
Currency translation (7,949) 11,788
Ending balance 376,493 392,717
Diagnostics and Genomics [Member]    
Beginning balance 450,350 355,229
Acquisitions   94,970
Acquisitions (4,407)  
Currency translation (335) 151
Ending balance $ 445,608 $ 450,350